PUTATIVE MEDIATORS OF INSULIN SECRETION
PUTATIVE MEDIATORS OF INSULIN SECRETION
批准号:
2905232
负责人:
SUZANNE Gale LAYCHOCK
金额:
$17.63万
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
已结题
起止时间:
1979-07-01 至 2001-06-30
关键词:
acetyl coA carboxylase adenylate cyclase antioxidants behavioral /social science research tag biological signal transduction cytokine enzyme induction /repression heme oxygenase hormone regulation /control mechanism hyperglycemia insulin insulin dependent diabetes mellitus insulin sensitivity /resistance laboratory rat noninsulin dependent diabetes mellitus oxidative stress pancreatic islet function phospholipase A2 phospholipase C protein kinase protein kinase A psychological stressor second messengers stress proteins
中文摘要
胰岛β(B)细胞分泌胰岛素,
各种形式的压力会影响B细胞的调节
和分泌的特定方式,并引发应激反应,
保护B细胞。分泌物改变时,
B细胞对葡萄糖的敏感性降低(脱敏),如
高血糖和非胰岛素依赖型糖尿病模型
(NIDDM)。B细胞也可能受到其他应激因素的抑制,如
作为细胞因子,使得胰岛素分泌减少或不存在,如
胰岛素依赖型糖尿病(IDDM)模型。长期
本研究的目的是确定信号转导事件,
参与B细胞发病的代谢过程
脱敏和与压力相关的事件的进展
反应和B细胞毒性。体外胰岛或B细胞模型将
可以研究模拟某些体内过程,
高血糖症/NIDDM或IDDM的形式。目的(1)是表征短
腺苷酸环化酶的长期脱敏/下调
胰岛在葡萄糖诱导的脱敏过程中。腺苷酸
将在分离的胰岛中表征环化酶活性和表达
和胰岛素瘤细胞。目的(2)定义应激反应细胞
B细胞中的介质。压力源包括:葡萄糖(高或低
浓度)、细胞因子、热休克和氧化应激。应力
待评估的反应包括:热休克蛋白,应激激活的
蛋白激酶,血红素加氧酶诱导,腺苷
单磷酸介导的蛋白激酶(AMPK)和乙酰辅酶A羧化酶
活性和抗氧化酶诱导/活化。未来
治疗策略将受益于提高认识,
与压力相关的特定B细胞反应。目标(3)是
表征磷酸肌醇的活性和表达,
磷脂酰胆碱特异性磷脂酶C(PLC),在B细胞
应力PLC衍生的甘油二酯可介导特异性应激反应
在B细胞中,与鞘磷脂酶活化、神经酰胺产生
和核转录事件。这些研究的重要性在于,
将在B细胞中探索新的信号转导机制,
在高血糖症和B细胞
细胞毒这些研究的结果将增加我们的知识
关于参与病理性的调节途径,
作为与胰岛素从B-
细胞,并将导致更完整的了解糖尿病
用于未来涉及细胞生物学的治疗干预。
英文摘要
The pancreatic islet beta (B)-cell secretes insulin, and the hypothesis
to be tested is that various forms of stress affects B-cell regulation
and secretion in specific ways, and that stress responses are invoked
which are protective of the B-cell. Secretion is altered when the
sensitivity of the B-cell to glucose is reduced (desensitized), as in
models of hyperglycemia and non-insulin-dependent diabetes mellitus
(NIDDM). The B-cell may also be inhibited by other stress factors, such
as cytokines, such that insulin secretion is reduced or absent, as in
models of insulin-dependent diabetes mellitus (IDDM). The long-term
goals of this study are to determine the signal transduction events and
metabolic processes which participate in the onset of B-cell
desensitization and the progression of events associated with stress
responses and B-cell cytotoxicity. in vitro islet or B-cell models will
be studied which mimic certain of the in vivo processes associated with
forms of hyperglycemia /NIDDM or IDDM. Aim (l) is to characterize the short
and long-term desensitization/down-regulation of adenylyl cyclase in
pancreatic islets during glucose-induced desensitization. Adenylyl
cyclase activity and expression will be characterized in isolated islets
and insulinoma cells. Aim (2) is to define the stress response cellular
mediators in B-cells. Stressors include: glucose (high or low
concentrations), cytokines, heat shock and oxidative stress. Stress
responses to be evaluated include: heat shock proteins, stress-activated
protein kinases (SAPKs), heme oxygenase induction, adenosine
monophosphate-mediated protein kinase (AMPK) and acetyl-CoA carboxylase
activity, and antioxidant enzyme induction/activation. Future
therapeutic strategies will benefit from increased awareness of the
specific B-cell responses associated with stress. Aim (3) is to
characterize the activity and expression of phosphoinositide- and
phosphatidylcholine-specific phospholipase C (PLC), during B-cell
stress. PLC-derived diacylglycerol may mediate specific stress responses
in B-cells related to shingomyelinase activation, ceramide production
and nuclear transcription events.The importance of these studies is that
novel signal transducing mechanisms will be explored in B-cells and
characterized regarding their role in models of hyperglycemia and B-cell
cytotoxicity. The results of these studies will increase our knowledge
concerning regulatory pathways which participate in pathological as well
as physiological processes associated with insulin release from the B-
cell, and will lead to more complete understanding of diabetes mellitus
for future therapeutic interventions involving cellular biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulated insulin secretion from tissue engineered skin*
-
批准号:6931570
-
项目类别:
-
资助金额:$3.93万
-
财政年份:2004
-
负责人:SUZANNE Gale LAYCHOCK
-
依托单位:
Regulated insulin secretion from tissue engineered skin*
-
批准号:6827228
-
项目类别:
-
资助金额:$3.93万
-
财政年份:2004
-
负责人:SUZANNE Gale LAYCHOCK
-
依托单位:
PUTATIVE MEDIATORS OF INSULIN SECRETION
-
批准号:2137775
-
项目类别:
-
资助金额:$14.5万
-
财政年份:1979
-
负责人:SUZANNE Gale LAYCHOCK
-
依托单位:
PUTATIVE MEDIATORS OF INSULIN SECRETION
-
批准号:6176614
-
项目类别:
-
资助金额:$18.15万
-
财政年份:1979
-
负责人:SUZANNE Gale LAYCHOCK
-
依托单位:
PUTATIVE MEDIATORS OF INSULIN SECRETION
-
批准号:3227555
-
项目类别:
-
资助金额:$1.57万
-
财政年份:1979
-
负责人:SUZANNE Gale LAYCHOCK
-
依托单位:
PUTATIVE MEDIATORS OF INSULIN SECRETION
-
批准号:3227554
-
项目类别:
-
资助金额:$12.58万
-
财政年份:1979
-
负责人:SUZANNE Gale LAYCHOCK
-
依托单位:
PUTATIVE MEDIATORS OF INSULIN SECRETION
-
批准号:3227549
-
项目类别:
-
资助金额:$12.17万
-
财政年份:1979
-
负责人:SUZANNE Gale LAYCHOCK
-
依托单位:
PUTATIVE MEDIATORS OF INSULIN SECRETION
-
批准号:3227557
-
项目类别:
-
资助金额:$13.15万
-
财政年份:1979
-
负责人:SUZANNE Gale LAYCHOCK
-
依托单位:
PUTATIVE MEDIATORS OF INSULIN SECRETION
-
批准号:2137776
-
项目类别:
-
资助金额:$15.44万
-
财政年份:1979
-
负责人:SUZANNE Gale LAYCHOCK
-
依托单位:
PUTATIVE MEDIATORS OF INSULIN SECRETION
-
批准号:2410070
-
项目类别:
-
资助金额:$16.52万
-
财政年份:1979
-
负责人:SUZANNE Gale LAYCHOCK
-
依托单位:
PUTATIVE MEDIATORS OF INSULIN SECRETION
-
批准号:2733988
-
项目类别:
-
资助金额:$17.12万
-
财政年份:1979
-
负责人:SUZANNE Gale LAYCHOCK
-
依托单位:
PUTATIVE MEDIATORS OF INSULIN SECRETION
-
批准号:3227551
-
项目类别:
-
资助金额:$13.76万
-
财政年份:1979
-
负责人:SUZANNE Gale LAYCHOCK
-
依托单位:
PUTATIVE MEDIATORS OF INSULIN SECRETION
-
批准号:3227556
-
项目类别:
-
资助金额:$12.82万
-
财政年份:1979
-
负责人:SUZANNE Gale LAYCHOCK
-
依托单位:
PUTATIVE MEDIATORS OF INSULIN SECRETION
-
批准号:3227553
-
项目类别:
-
资助金额:$9.76万
-
财政年份:1979
-
负责人:SUZANNE Gale LAYCHOCK
-
依托单位:
PUTATIVE MEDIATORS OF INSULIN SECRETION
-
批准号:3227558
-
项目类别:
-
资助金额:$11.4万
-
财政年份:1979
-
负责人:SUZANNE Gale LAYCHOCK
-
依托单位:
PUTATIVE MEDIATORS OF INSULIN SECRETION
-
批准号:3151540
-
项目类别:
-
资助金额:$9.83万
-
财政年份:1979
-
负责人:SUZANNE Gale LAYCHOCK
-
依托单位:
PUTATIVE MEDIATORS OF INSULIN SECRETION
-
批准号:2137774
-
项目类别:
-
资助金额:$14.28万
-
财政年份:1979
-
负责人:SUZANNE Gale LAYCHOCK
-
依托单位:
海外基金